clinical trial · NCT01920737
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
LeukemiaDaunorubicinVincristinePrednisonePEG-AsparaginaseMethotrexate6-MP (6-Mercaptopurine)CyclophosphamideCytarabine
brief summary
The purpose of the study is to find out whether the combination of chemotherapy drugs that are routinely used in children with ALL, will be safe and effective in treating adult patients with ALL. The standard treatment for adults with ALL consists of many chemotherapy drugs that are given in different combinations and in several steps. In adult ALL there is no standard which drugs to give and how to combine them. Some leukemias have a chromosome abnormality called Philadelphia chromosome (also called Ph Positive) and some leukemias do not (called Ph Negative). In this study we want to see whether this combination of chemotherapy drugs will be safe and effective in treating adult patients with Ph Negative ALL.
started
Aug 7, 2013
primary completion
Aug 1, 2027
completion
Aug 1, 2027
last updated
Sep 15, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol